Pharma Archives - Boston Life Sciences Times

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

January 6, 2026

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

January 5, 2026

instED Names Don Stiffler Chief Executive Officer

December 29, 2025

THIS WEEK'S STORIES

Elemental Machines Launches Agentic AI Platform to Drive Autonomous Decision-Making in Life Sciences Operations

January 8, 2026

VideaHealth Launches AI Leadership Council to Guide Responsible Use of Artificial Intelligence in Dentistry

January 7, 2026

Nimbus Therapeutics, Lilly Enter Research Collaboration and License Agreement for Oral Obesity Treatment

January 6, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Amylyx Selects AMX0318 as Development Candidate for Post-Bariatric Hypoglycemia and Rare Diseases

International Institute of New England Honors Alnylam CEO Dr. Yvonne Greenstreet With 2026 Golden Door Award

Kelonia Therapeutics Receives FDA Clearance to Advance KLN-1010 In Vivo CAR-T Therapy for Multiple Myeloma

Sarepta Submits Clinical Trial Application for First-in-Human Study of SRP-1005 in Huntington’s Disease

Ventus Therapeutics Names VENT-04 as Development Candidate for Inflammatory Diseases

Most Read

ZOLL Launches Next-Generation LifeVest Wearable Defibrillator in U.S.

Allotex Receives FDA Clearance to Begin U.S. Clinical Study for Presbyopia Device

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS

Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs

EDITOR PICKS